Lisata Therapeutics Inc.

NASDAQ: LSTA · Real-Time Price · USD
2.52
-0.04 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
2.53
0.40%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lisata Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-19.98M -20.84M -54.23M -27.47M
Depreciation & Amortization
174K 189K 69K 55K
Stock-Based Compensation
1.65M 2.04M 2.64M 2M
Other Working Capital
1.02M -550K -608K -603K
Other Non-Cash Items
-325K -957K 31.18M 2.51M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-873K -462K -831K 647K
Operating Cash Flow
-19.36M -20.03M -21.17M -22.25M
Capital Expenditures
n/a n/a -285K -60K
Cash Acquisitions
-130K n/a -3.32M 54.84K
Purchase of Investments
-55.69M -98.48M -89.69M -179.78M
Sales Maturities Of Investments
69.05M 108.58M 122.2M 124.94M
Other Investing Acitivies
n/a n/a n/a -54.84K
Investing Cash Flow
13.23M 10.1M 28.91M -54.9M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-274K 64K -267K -224K
Financial Cash Flow
-206K 385K -224K 85.28M
Net Cash Flow
-6.38M -9.56M 7.51M 8.13M
Free Cash Flow
-19.36M -20.03M -21.45M -22.3M